CME Group Inc. Financials

Market Capitalization $84.10 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	24.57
Forward PE	22.51
Price to Sales TTM	$13.94
Price to Book MRQ	$2.97
Enterprise to Revenue	14.17
Enterprise to EBITDA	20.31

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	57.43%
Operating Margin	64.75%
Return on Assets TTM	1.84%
Return on Equity TTM	12.30%

Income Statement

Revenue TTM	$6,034,400,256
Revenue per Share TTM	$16.80
Quarterly Revenue Growth	18.50%
Gross Profit TTM	$6,034,400,256
EBITDA	$730,900,000
Net Income to Common TTM	$3,422,099,968
Diluted EPS TTM	$9.50
Quarterly Earnings Growth YoY	21.70%

Balance Sheet

Total Cash MRQ	$2,434,400,000
Total Cash per Share MRQ	$6.76
Total Debt MRQ	$
Total Debt to Equity MRQ	13.62
Current Ratio MRQ	1.02
Book Value per Share MRQ	$78.47

Cash Flow

Operating Cash Flow TTM	$3,716,900,096
Levered Free Cash Flow TTM	$2,513,037,568

CME Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	360,359,008
Float Shares	358,769,400
Avg 10 Volume	2,012,780
Avg 30 Volume	None
Shares Short	4,320,607
Short Ratio	1.87
Short % of Shares	1.20%
% Held by Insiders	0.45%
% Held by Institutions	89.39%

Stock Price Summary

Beta	0.56
Fifty Two Week Low	$190.70
Fifty Two Week High	$249.02
Fifty Two Week Change	12.74%
Day 50 MA	$233.00
Day 200 MA	$215.72

Dividends and Splits

Forward Annual Dividend Rate	$23.20
Forward Annual Dividend Yield	9.89%
Trailing Annual Dividend Rate	$9.25
Trailing Annual Dividend Yield	3.94%
Payout Ratio	103.05%
Dividend Date	2025-01-16
Ex Dividend Date	2024-12-27
Last Split Factor
Last Split Date	2012-07-23